1ST Biotherapeutics, Inc.
1ST Biotherapeutics, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects | Healthy | Not yet recruiting | Phase 1 | 2026-09-02 | NCT07126704 | |
| A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2025-08-17 | NCT05761223 | |
| A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418 | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 1 | 2024-12-02 | NCT05995782 |